Nanomedicine utilizes engineered nanoparticles for advanced healthcare applications, such as imaging and drug delivery, but faces challenges in precise analysis of elemental impurities and particle composition.
Current pharmaceutical guidelines emphasize total elemental impurity concentration, lacking differentiation between free ions and nanoparticle forms, crucial for assessing safety and efficacy.
A new analytical technique developed by Assistant Professor Yu-ki Tanaka's team at Chiba University enables the differentiation and quantification of metal ionic and nanoparticle states in nanomedicines.
This breakthrough method utilizes asymmetrical flow field-flow fractionation (AF4) coupled with inductively coupled plasma mass spectrometry (ICP-MS) to assess elemental impurities and particle size distribution effectively.
Validation using Resovist®, an iron-based contrast agent, showed minimal ionic iron content and optimal nanoparticle sizes for enhanced biological performance and safety.
This innovative approach benefits various industries beyond healthcare, offering a comprehensive tool for analyzing metal-containing samples for safety assessments and quality control.
The AF4-ICP-MS technique revolutionizes nanoparticle characterization by providing detailed insights into particle distribution and elemental content, crucial for regulatory compliance and patient health.
By accurately quantifying particle aggregates and free ions, this method enhances nanomedicine quality control, ensuring consistency and safety in manufacturing processes.
The method's applications extend to environmental assessments and food safety regulations, offering insights into metal contaminants and additives for public health protection.
Assistant Professor Yu-ki Tanaka's expertise in heavy metal analysis and single-cell/particle techniques contributes significantly to advancing nanomedicine characterization and scientific research.